Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CBRE Group | CBRE | Nov 22, 2024 | 135.43 | +2.87 |
CCC Intelligent Solutions | CCCS | Nov 22, 2024 | 12.47 | +1.05 |
CCSC Technology International A | CCTG | Nov 22, 2024 | 1.78 | +3.49 |
CDT Environmental Technology Investment Holdings | CDTG | Nov 22, 2024 | 3.20 | -3.90 |
CDW | CDW | Nov 22, 2024 | 178.96 | +0.44 |
CEA Industries | CEAD | Nov 22, 2024 | 6.00 | +0.45 |
CECO Environmental | CECO | Nov 22, 2024 | 31.36 | +3.84 |
Cedar Realty Trust B Pref | CDR-B | Nov 22, 2024 | 15.81 | +1.44 |
Cedar Realty Trust C Pref | CDR-C | Nov 22, 2024 | 14.10 | 0.00 |
CEF Income Composite Powershares | PCEF | Nov 22, 2024 | 19.50 | +0.33 |
Cel-Sci | CVM | Nov 22, 2024 | 0.60 | -1.44 |
Celanese | CE | Nov 22, 2024 | 74.70 | -0.40 |
Celcuity | CELC | Nov 22, 2024 | 13.19 | +3.61 |
Celestica | CLS | Nov 22, 2024 | 89.16 | -2.49 |
Celldex Therapeutics | CLDX | Nov 22, 2024 | 27.02 | +3.05 |
Cellebrite | CLBT | Nov 22, 2024 | 19.72 | -2.28 |
Cellectar Biosciences | CLRB | Nov 22, 2024 | 1.58 | 0.00 |
Cellectis ADR | CLLS | Nov 22, 2024 | 1.87 | +0.54 |
Celsius | CELH | Nov 22, 2024 | 29.31 | +0.90 |
Celularity A | CELU | Nov 22, 2024 | 2.76 | -3.16 |
Cementos Pacasmayo ADR | CPAC | Nov 22, 2024 | 5.79 | -2.45 |
CEMEX ADR | CX | Nov 22, 2024 | 5.50 | +0.92 |
Cemtrex | CETX | Nov 22, 2024 | 0.11 | -41.59 |
Cencora | COR | Nov 22, 2024 | 245.02 | -0.27 |
Cenntro | CENN | Nov 22, 2024 | 1.25 | +1.22 |
Cenovus Energy | CVE | Nov 22, 2024 | 16.19 | -0.06 |
Centene | CNC | Nov 22, 2024 | 60.37 | +0.03 |
CenterPoint Energy | CNP | Nov 22, 2024 | 31.93 | +0.63 |
Centerra Gold | CGAU | Nov 22, 2024 | 6.24 | -0.32 |
Centerspace | CSR-C | Nov 22, 2024 | 24.98 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.